Crude oil fell sharply Wednesday as persistent market instability and weak global demand outweighed Russian sanctions, with prices eyeing support near $55–$56.
An improved outlook, a year-over-year decline in earnings per share, contracting margins, and rising medical costs create an engaging narrative for UnitedHealth Group. Should you buy the sell-off?